How did Helen of Troy Ltd (HELE) fare last session?

While Helen of Troy Ltd has overperformed by 3.95%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HELE fell by -47.70%, with highs and lows ranging from $90.10 to $24.15, whereas the simple moving average fell by -39.37% in the last 200 days.

On July 10, 2024, DA Davidson Downgraded Helen of Troy Ltd (NASDAQ: HELE) to Neutral. A report published by UBS on April 17, 2023, Initiated its previous ‘Neutral’ rating for HELE. DA Davidson also Upgraded HELE shares as ‘Buy’, setting a target price of $126 on the company’s shares in a report dated December 22, 2022. Canaccord Genuity Initiated an Buy rating on November 17, 2022, and assigned a price target of $120. Raymond James initiated its ‘Mkt Perform’ rating for HELE, as published in its report on July 13, 2022. Sidoti’s report from February 07, 2022 suggests a price prediction of $263 for HELE shares, giving the stock a ‘Buy’ rating. DA Davidson also rated the stock as ‘Neutral’.

Analysis of Helen of Troy Ltd (HELE)

Further, the quarter-over-quarter decrease in sales is -1.01%, showing a negative trend in the upcoming months.

One of the most important indicators of Helen of Troy Ltd’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 7.45% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.03, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can also provide valuable insight into volatility, and HELE is recording 750.79K average volume. On a monthly basis, the volatility of the stock is set at 5.41%, whereas on a weekly basis, it is put at 8.83%, with a gain of 10.25% over the past seven days. Furthermore, long-term investors anticipate a median target price of $46.33, showing growth from the present price of $31.29, which can serve as yet another indication of whether HELE is worth investing in or should be passed over.

How Do You Analyze Helen of Troy Ltd Shares?

The Household & Personal Products market is dominated by Helen of Troy Ltd (HELE) based in the Bermuda. When comparing Helen of Troy Ltd shares with other companies under Consumer Defensive, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 5.80, there is a growth in quarterly earnings of 24.29%.

Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.99%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 105.06% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

HELE shares are owned by institutional investors to the tune of 105.06% at present.

Hot this week

Can you now get a good deal on Spero Therapeutics Inc’s shares?

While Spero Therapeutics Inc has overperformed by 1.38%, investors...

Petco Health and Wellness Co Inc (WOOF) deserves closer scrutiny

While Petco Health and Wellness Co Inc has underperformed...

ORIC Pharmaceuticals Inc (ORIC) produces promising results

While ORIC Pharmaceuticals Inc has underperformed by -2.07%, investors...

How did E.W. Scripps Co (SSP) fare last session?

While E.W. Scripps Co has overperformed by 5.56%, investors...

Topics

Can you now get a good deal on Spero Therapeutics Inc’s shares?

While Spero Therapeutics Inc has overperformed by 1.38%, investors...

Petco Health and Wellness Co Inc (WOOF) deserves closer scrutiny

While Petco Health and Wellness Co Inc has underperformed...

ORIC Pharmaceuticals Inc (ORIC) produces promising results

While ORIC Pharmaceuticals Inc has underperformed by -2.07%, investors...

How did E.W. Scripps Co (SSP) fare last session?

While E.W. Scripps Co has overperformed by 5.56%, investors...

Is Talkspace Inc (TALK) a opportunity to investors?

While Talkspace Inc has overperformed by 3.02%, investors are...

Can you still get a good price for Vox Royalty Corp (VOXR) Shares at this point?

While Vox Royalty Corp has underperformed by -7.06%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.